Skip to main content
. 2023 Mar 16;21:2110–2118. doi: 10.1016/j.csbj.2023.03.014

Fig. 2.

Fig. 2

Use of biomarkers per therapeutic area (as a proportion of clinical trials in the area per year) spanning 20 years of clinical trials.